COVID-19: emergency regulations and affected legislative procedures

Written by CBD-Intel || 23rd September 2020 || Alerts roundup |

COVID-19

Health

Regulation and Legislation

Alerts roundup

Find all of CBD-Intel’s coronavirus-related regulatory alerts here, updated as they appear ...

Ale and hearty – a new CBD food and drinks trade springs up in Hong Kong

Written by CBD-Intel || 23rd September 2020 || Business briefing |

Asia

Hong Kong

Companies

Food

Marketing and Retailing

Technology and Innovation

Business briefing

2020 seems an unlikely year for the emergence of any new industry, yet this is exactly what has happened in Hong Kong, where there are now locally produced CBD food and drink products ...

Why do bills related to cannabinoids keep getting pushed through the US Congress?

Written by CBD-Intel || 21st September 2020 || Blog |

North America

United States

Policy and Politics

Regulation and Legislation

Blog

There does not seem to be much point in continuing to try to force through bills – particularly given that the Republican-controlled senate and presidency opposes any measures and the limited timeframe before the end of the legislative session....

CBD-Intel regulatory news in brief, 12th-18th September

Written by CBD-Intel || 18th September 2020 || Alerts roundup |

Argentina

Asia

Ecuador

Europe

France

Israel

Italy

Michigan

New York

North America

Philippines

Poland

Russia

South America

Sweden

United States

World

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from France, Italy, Poland, Sweden, the US, the British Virgin Islands, Argentina, Australia, Ecuador, Israel, the Philippines and Russia ...

cbdMD campaign steps carefully to find the right route to TV ad acceptance

Written by CBD-Intel || 18th September 2020 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

A TV advertising campaign for US company cbdMD demonstrates how attitudes towards CBD products are slowly changing in advertising circles – but also how much work remains to be done ...

British spirit-makers looking to make CBD the gin genie in the bottle

Written by CBD-Intel || 16th September 2020 || Business briefing |

Europe

United Kingdom

Companies

Marketing and Retailing

Technology and Innovation

Business briefing

Britain’s newfound enthusiasm for CBD products has joined with the passion for alcohol, with some companies are aiming to capitalise on the trend for “drinking less but drinking better” by launching CBD spirits, especially gin ...

Opposing politicians attack European Commission view on ‘narcotic’ CBD

Written by CBD-Intel || 15th September 2020 || Regulatory briefing |

Czech Republic

EU

Europe

Poland

EU regulation

Regulatory briefing

MEPs with very different political outlooks have attacked the European Commission’s initial opinion that CBD could be classed under United Nations conventions as a narcotic ...

Researchers suggest CBD could work with terpenes in COVID-19 treatment

Written by CBD-Intel || 14th September 2020 || Business briefing |

Asia

Canada

Israel

North America

COVID-19

Health

Science

Technology and Innovation

Business briefing

Studies looking at the potential for CBD to treat or alleviate COVID-19 symptoms continue to progress – with one study hinting at promising results combining CBD with other terpene products ...

CBD-Intel regulatory news in brief, 5th-11th September

Written by CBD-Intel || 11th September 2020 || Alerts roundup |

Asia

Colombia

Czech Republic

EU

Europe

France

Germany

Iowa

Ireland

Israel

Lithuania

Maine

Malta

Netherlands

North America

Oklahoma

Russia

Slovakia

South America

Switzerland

Ukraine

United Kingdom

United States

World

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from Czech Republic, France, Germany, Ireland, Lithuania, Malta, Netherlands, Slovakia, Ukraine, the UK, the US, Colombia, Israel and Russia ...

‘We want MORE’ – US Democrats prepare for House vote on cannabis reform bill

Written by CBD-Intel || 11th September 2020 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

US federal regulation

Regulatory briefing

The US House of Representatives is expected to hold a historic vote this month on a comprehensive cannabis reform bill that supporters embrace for not only decriminalising marijuana but correcting injustices ...

CBD industry steps up with funding for ValidCare’s vital liver function study

Written by CBD-Intel || 7th September 2020 || Business briefing |

North America

United States

Companies

Regulation and Legislation

Science

US federal regulation

Business briefing

More than a dozen CBD businesses have given their backing to an investigation of the impact of CBD on liver toxicity levels in order to provide regulatory authorities in the US with reliable new data ...

CBD-Intel regulatory news in brief, 22th August-4th September

Written by CBD-Intel || 4th September 2020 || Alerts roundup |

Asia

Australasia

Belgium

Brazil

California

Canada

Chile

Colombia

Europe

Florida

Germany

Hawaii

Indonesia

Israel

Malta

Nebraska

New Zealand

North America

Oklahoma

Pakistan

Paraguay

Pennsylvania

Peru

South America

United States

Vermont

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from Belgium, Germany, Malta, Canada, the US, Brazil, Chile, Colombia, Indonesia, Israel, New Zealand, Pakistan, Paraguay and Peru ...

What impact would the US Drug Enforcement Agency (DEA) rules have on the CBD industry if they were enacted in their current form?

Written by CBD-Intel || 4th September 2020 || Blog |

North America

United States

Regulation and Legislation

US federal regulation

Blog

First it's important to note that the DEA proposals are only in a draft form and are open to comment until 20th October. They have already received a large number of comments, the majority of which appear to...

Licensing difficulties hold back hemp producers in China’s Yunnan province

Written by CBD-Intel || 3rd September 2020 || Regulatory briefing |

Asia

China

Companies

Regulation and Legislation

Regulatory briefing

Companies seeking licences to produce hemp in the Chinese province of Yunnan face a tightening of the application process, according to some who have successfully negotiated the concealed hurdles ...

UK CBD oil price change index

Written by CBD-Intel || 3rd September 2020 || Charts and infographics |

Europe

United Kingdom

Market Research

Marketing and Retailing

Charts and infographics

The average price changes for standard and specialist CBD oils in the...

Podcast: what can European markets do with CBD Novel Food applications?

Written by CBD-Intel || 2nd September 2020 || Podcasts , Resources |

Europe

World

Companies

Food

Health

Market Research

Marketing and Retailing

Regulation and Legislation

Podcasts

Resources

CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European...

CBD-Intel global alerts database September

Written by CBD-Intel || 1st September 2020 || Alerts roundup |

Afghanistan

Africa

Alabama

Alaska

Albania

Algeria

Andorra

Argentina

Arizona

Arkansas

Armenia

Armenia

Asia

Australasia

Australia

Austria

Bahrain

Bangladesh

Belarus

Belgium

Bosnia and Herzegovina

Brazil

Bulgaria

California

Cambodia

Canada

Chile

China

Colombia

Colorado

Connecticut

Croatia

Cyprus

Czech Republic

Delaware

Democratic Republic of the Congo

Denmark

Ecuador

Egypt

England

Estonia

Ethiopia

EU

Europe

Finland

Florida

France

Georgia

Georgia

Germany

Greece

Hawaii

Honduras

Hong Kong

Hungary

Iceland

Idaho

Illinois

India

Indiana

Indonesia

Iowa

Iran

Iraq

Ireland

Isle of Man

Israel

Italy

Japan

Kansas

Kazakhstan

Kentucky

Kenya

Kosovo

Kuwait

Kyrgyzstan

Latvia

Lesotho

Libya

Lithuania

Louisiana

Luxemburg

Macedonia

Maine

Malaysia

Malta

Maryland

Massachusetts

Mauritania

Mexico

Michigan

Middle East

Minnesota

Mississippi

Missouri

Moldova

Monaco

Montana

Montenegro

Morocco

Mozambique

Myanmar

Namibia

Nebraska

Nepal

Netherlands

Nevada

New Hampshire

New Jersey

New Mexico

New York

New Zealand

Nigeria

North America

North Carolina

North Dakota

North Korea

Northern Ireland

Norway

Ohio

Oklahoma

Oman

Oregon

Pakistan

Paraguay

Pennsylvania

Peru

Philippines

Poland

Portugal

Puerto Rico

Qatar

Rhode Island

Romania

Russia

San Marino

Saudi Arabia

Scandinavia

Scotland

Serbia

Singapore

Slovakia

Slovenia

South Africa

South America

South Carolina

South Dakota

South Korea

Spain

Sri Lanka

Sudan

Sweden

Switzerland

Syria

Taiwan

Tanzania

Tennessee

Texas

Thailand

Tunisia

Turkey

Uganda

Ukraine

United Arab Emirates

United Kingdom

United States

Uruguay

Utah

Uzbekistan

Vatican City

Venezuela

Vermont

Vietnam

Virginia

Wales

Washington

Washington D.C.

West Virginia

Wisconsin

World

Wyoming

Yemen

Zimbabwe

Policy and Politics

Regulation and Legislation

Alerts roundup

All the stories from the CBD-Intel weekly global regulatory Live Alerts in one user-friendly database, updated every month. This regulatory tool consolidates all of our global regulatory Live Alerts since they were launched in May 2019, collected in Excel...

Netherlands CBD price reductions

Written by CBD-Intel || 31st August 2020 || Charts and infographics |

Europe

Netherlands

Market Research

Marketing and Retailing

Charts and infographics

The percentage of price reductions for brands and products within prominent CBD categories in the...

CBD-Intel regulatory news in brief, 22nd-28th August

Written by CBD-Intel || 28th August 2020 || Alerts roundup |

Asia

Czech Republic

Ecuador

Europe

Israel

Mexico

North America

Pennsylvania

South America

Sweden

United States

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief includes updates from the Czech Republic, Sweden, Mexico, the US, Ecuador and Israel ...

How significant is Charlotte’s Web being denied a trademark?

Written by CBD-Intel || 27th August 2020 || Blog |

North America

United States

Companies

Regulation and Legislation

Blog

The immediate impact of the decision is a reduction in certainty for CBD firms - not something they need at a time of significantly heightened uncertainty in other...

Worse delays feared for European CBD novel food authorisations

Written by CBD-Intel || 27th August 2020 || Regulatory briefing |

EU

Europe

EU regulation

Food

Regulation and Legislation

Regulatory briefing

Do not expect European novel food authorisations before the end of 2022 at the very earliest and do not expect generic authorisations to cover non-applicant products, a new report from CBD-Intel warns ...

Charlotte’s Web denied US trademark on appeal ‘because CBD oil isn’t legal’

Written by CBD-Intel || 26th August 2020 || Regulatory briefing |

North America

United States

Companies

Food

Regulation and Legislation

US federal regulation

Regulatory briefing

Charlotte's Web has been denied a US trademark on appeal – a ruling that has serious implications for any company in the CBD sector selling food, drink or dietary supplement products in the US ...

German firm waits to hear whether new CBD oil will be deemed ‘novel food’

Written by CBD-Intel || 24th August 2020 || Business briefing |

EU

Europe

Germany

Companies

EU regulation

Food

Policy and Politics

Regulation and Legislation

Business briefing

A German company is still waiting to hear from the authorities two months after launching new CBD products that could be considered food supplements ...

CBD-Intel regulatory news in brief, 15th-21st August

Written by CBD-Intel || 21st August 2020 || Alerts roundup |

Africa

Argentina

Asia

Australasia

Brazil

Canada

Europe

France

Germany

Israel

Mexico

New York

New Zealand

North America

Poland

South Africa

South America

Texas

United Kingdom

United States

Uruguay

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief brings updates from France, Germany, Poland, the UK, Canada, Mexico, the US, Argentina, Brazil, Israel, New Zealand, South Africa and Uruguay ...

What can be made of Canopy’s increased interest in functional ingredients?

Written by CBD-Intel || 21st August 2020 || Blog |

Canada

North America

United States

Food

Health

Regulation and Legislation

US federal regulation

Blog

Canopy, the Canadian cannabinoid company, has continued to commit heavily to BioSteel, a sports nutrition company in which Canopy now owns the majority share....

Greece new CBD product analysis

Written by CBD-Intel || 21st August 2020 || Charts and infographics |

Europe

Greece

Market Research

Marketing and Retailing

Charts and infographics

An analysis of the new CBD products launched in Greece and the up and coming product categories....

Italian tobacconists lobby for a monopoly on the sale of CBD flowers

Written by CBD-Intel || 20th August 2020 || Business briefing |

Europe

Italy

Marketing and Retailing

Regulation and Legislation

Retail

Business briefing

A group of tobacco retailers have written to the Italian Tobacconists Federation (FIT) asking it to push for a state monopoly on the sale of CBD flowers ...

Number of US brands offering product categories

Written by CBD-Intel || 17th August 2020 || Charts and infographics |

North America

United States

Market Research

Marketing and Retailing

Charts and infographics

The product offerings of US CBD brands per product category, and how they have changed this quarter....

Switzerland edges towards legal cannabis with trials likely next year

Written by CBD-Intel || 17th August 2020 || Regulatory briefing |

Europe

Switzerland

Policy and Politics

Regulation and Legislation

Vapour/Smokable

Regulatory briefing

Switzerland plans to launch trials next year as part of a move toward legalising cannabis with high levels of THC – but it could be several years before Swiss users can legally light up a joint ...

CBD-Intel regulatory news in brief, 8th-14th August

Written by CBD-Intel || 14th August 2020 || Alerts roundup |

Africa

Asia

Canada

Cyprus

Czech Republic

Europe

France

Germany

Israel

Italy

Massachusetts

Mexico

Nebraska

North America

Panama

Paraguay

South Africa

South America

Switzerland

Texas

United States

Uruguay

Washington D.C.

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief brings updates from Czech Republic, Cyprus, France, Germany, Italy, Switzerland, Canada, Mexico, the US, Israel, Panama, Paraguay, South Africa and Uruguay ...

Why does the European Commission (EC) think CBD may be a narcotic?

Written by CBD-Intel || 14th August 2020 || Blog |

Europe

United States

Food

Regulation and Legislation

US federal regulation

Blog

The opinion (which is not yet set by the EC but appears to be the way the organisation is thinking) is based on a literal reading of the 1961 UN Narcotics...

Nanotechnology could improve the therapeutic potential of cannabinoids

Written by CBD-Intel || 13th August 2020 || Business briefing |

Science

Technology and Innovation

Business briefing

Nanotechnology – referring to any kind of technology dealing in very small scales such as atomic, molecular or supramolecular – could improve some of the disadvantages of cannabinoids, such as solubility ...

US FDA provides cannabis researchers guidance on sources, testing and quality

Written by CBD-Intel || 12th August 2020 || Regulatory briefing |

Regulation and Legislation

Science

US federal regulation

Regulatory briefing

Clinical research guidance from the US Food and Drug Administration (FDA) should provide further impetus for cannabis research, which is certain to have an impact on the CBD market ...

The entourage effect – absence of evidence, but no evidence of absence

Written by CBD-Intel || 11th August 2020 || Business briefing |

Asia

Australasia

Australia

Israel

New Zealand

Science

Business briefing

Some recent research has cast doubt on the idea that cannabis compounds may be more effective when taken together ...

Studies suggest interesting potential for lesser known cannabinoids

Written by CBD-Intel || 7th August 2020 || Business briefing |

Health

Science

Business briefing

New research into the therapeutic potential of lesser known cannabinoids is progressing with recent discoveries about a host of new compounds ...

What can we expect from the US Food and Drug Administration (FDA) proposals to regulate CBD under review by the White House Office of Management and Budget (OMB)?

Written by CBD-Intel || 7th August 2020 || Blog |

North America

United States

Food

Regulation and Legislation

US federal regulation

Blog

Authorities have been very tight lipped about the details of the proposed regulations and little is known beyond the title of the document....

A list of regional Italian proposals for hemp regulation and promotion

Written by CBD-Intel || 6th August 2020 || Regulatory briefing |

Europe

Italy

Regulation and Legislation

Regulatory briefing

Italian regions are trying to boost the hemp-supply chain through proposed regional rules, funding projects and developing circular economy strategies to make up for the lack of clarifying action at the national level ...

Vaping shows to be best method of consumption for CBD bioavailability

Written by CBD-Intel || 6th August 2020 || Business briefing |

Science

Technology and Innovation

Business briefing

Scientists are increasingly starting to study how differing methods of consumption can affect CBD bioavailability – the ability to enter your bloodstream and induce effects ...

New Zealand cannabis legislation would also include legalising CBD products

Written by CBD-Intel || 5th August 2020 || Regulatory briefing |

Australasia

New Zealand

Regulation and Legislation

Regulatory briefing

New Zealand will go to the polls in just under two months to decide on a broad cannabis legalisation referendum that would also encompass fully legalising CBD products ...

CBD market trends & country comparison

Written by CBD-Intel || 4th August 2020 || Presentations , Resources |

World

Companies

Market Research

Marketing and Retailing

Technology and Innovation

Presentations

Resources

Maria Alejandra Estanga, one of CBD-Intel’s market analysts, presented the latest CBD market trends & country comparison at the CBD live during VOXPO - Virtual Online Vape & CBD Expo on 31st...

Regulatory report: Lithuania

Written by CBD-Intel || 4th August 2020 || Regulatory reports |

Europe

Lithuania

Regulation and Legislation

Regulatory reports

This regulatory report provides a detailed analysis of the current regulations in place in Lithuania, as well as discussing possible future legislation that could change the legal framework ...

Bluebird Botanicals sees success with unconventional advertising campaign

Written by CBD-Intel || 3rd August 2020 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

A US CBD company has taken an unusual approach to advertising to set itself apart from the pack. It is using a spare forceful campaign that actively discourages some people from using its products ...

Draft guidance on CBD enforcement submitted to OMB for review

Written by CBD-Intel || 3rd August 2020 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The FDA’s draft guidance on CBD enforcement policy was submitted for review by the White House Office of Management and Budget (OMB) and the OMB has now scheduled meetings with various hemp/CBD stakeholder groups ...

Regulatory report: EU narcotics law leaves question mark over future of CBD

Written by CBD-Intel || 3rd August 2020 || Regulatory reports |

EU

Europe

EU regulation

Regulatory reports

Confusion over whether CBD should be considered a narcotic drug has developed into a major question mark over the substance's future in Europe ...

CBD-Intel regulatory news in brief, 25th-31st July

Written by CBD-Intel || 31st July 2020 || Alerts roundup |

Africa

Asia

Bosnia and Herzegovina

Europe

Ghana

Indiana

New Mexico

North America

Paraguay

South America

Texas

Thailand

United States

Regulation and Legislation

Alerts roundup

This week's regulatory news in brief brings updates from Bosnia and Herzegovina, the US, Ghana, Paraguay and Thailand ...

Now that Swiss authorities have returned taxes, what is the industry planning to do?

Written by CBD-Intel || 31st July 2020 || Blog |

Europe

Switzerland

Companies

Food

Regulation and Legislation

US federal regulation

Blog

Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un...

Regulatory report: Russia

Written by CBD-Intel || 30th July 2020 || Regulatory reports |

Russia

World

Regulation and Legislation

Regulatory reports

Russia allows industrial hemp to be grown, but with limitations. This report provides an overview of the current regulatory regime in place for CBD and hemp in Russia ...

Ignite lost $50m in one year; auditors say survival now endangered

Written by CBD-Intel || 29th July 2020 || Business briefing |

Canada

North America

Companies

Business briefing

Canadian CBD firm Ignite lost $67m CAD last year and it could go under if it doesn’t get funding soon, auditors warned in an annual report ...

Swiss authorities return money after hemp flowers tax court ruling

Written by CBD-Intel || 28th July 2020 || Regulatory briefing |

Europe

Switzerland

Regulation and Legislation

Regulatory briefing

Switzerland’s customs authorities returned CHF33m (€30.5m) to CBD producers after the federal supreme court ruled there was no legal basis to tax hemp flowers under the country’s tobacco law...

Unwelcome but unsurprising: industry reactions to FDA testing

Written by CBD-Intel || 25th July 2020 || Regulatory briefing |

North America

United States

Health

Science

Regulatory briefing

The FDA’s recent report that fewer than half of the CBD products tested from US store shelves contain the amount of CBD on the label was unwelcome news ...